具有乙胆酶和碳酸酶抑制作用的新型二硫胺
Rafika El Ati1,2, Necla Öztaşkın2, Ahmet Çağan3
1Laboratory of Applied Chemistry and Environment (LCAE), Faculty of Sciences, University Mohammed the first, Oujda, Morocco.
Archiv der Pharmazie
|February 29, 2024
概括
新型硫胺被合成,对乙胆酶 (AChE) 和碳酸无水酶 (CA) 产生强烈的抑制作用. 这些化合物可能会导致对玻璃眼,和阿尔茨海默病的新疗法.
科学领域:
- 药用化学 医学化学
- 酶抑制研究 研究 酶抑制研究
背景情况:
- 乙胆化酶 (AChE) 和碳酸 anhydrases (CA) 是关键的酶,涉及神经系统疾病.
- 开发有效的ACHE和CA抑制剂对于治疗进步至关重要.
研究的目的:
- 为了合成和描述新的硫胺衍生物.
- 评估这些化合物的体外和内抑制活性,以对抗ACHE和CA.
主要方法:
- 从商用前体中合成硫胺衍生物.
- 酶抑制试验用于确定针对ACHE,CA I和CA II的抑制概况.
- 酶与抑制剂相互作用的计算分析 (in silico).
主要成果:
- 一系列新的硫胺胺 (化合物15-26) 已成功合成.
- 化合物在纳米分子范围内的Ki值对AChE表现出强烈的抑制作用.
- 对CA I和CA II观察到显著的抑制活性,同样具有纳米分子范围内的Ki值.
结论:
- 新合成的硫胺显示了有效的抗ACH和CA的抑制特征.
- 这些化合物代表了有希望的分子,用于治疗的发展.
- 潜在的应用包括治疗诸如玻璃眼,和阿尔茨海默病等疾病.
更多相关视频
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
565
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
565
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
673
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
673
Cholinergic Antagonists: Pharmacokinetics
439
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
439
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Anticholinesterase Agents: Poisoning and Treatment
856
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856


